Analysts Set The Joint Corp. (NASDAQ:JYNT) PT at $22.00

Shares of The Joint Corp. (NASDAQ:JYNT) have earned an average recommendation of “Moderate Buy” from the four brokerages that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $22.00.

JYNT has been the subject of several analyst reports. TheStreet downgraded shares of Joint from a “c-” rating to a “d” rating in a report on Thursday, March 7th. B. Riley upped their target price on Joint from $12.00 to $20.00 and gave the company a “buy” rating in a report on Monday. Roth Mkm reiterated a “buy” rating and set a $16.00 price target (up from $13.00) on shares of Joint in a report on Friday, May 3rd. Finally, StockNews.com upgraded Joint from a “hold” rating to a “buy” rating in a research note on Monday.

Institutional Trading of Joint

Several hedge funds have recently made changes to their positions in the company. Quantbot Technologies LP grew its stake in shares of Joint by 345.0% during the 3rd quarter. Quantbot Technologies LP now owns 4,170 shares of the company’s stock worth $37,000 after acquiring an additional 3,233 shares during the period. Barclays PLC lifted its holdings in Joint by 29.4% during the third quarter. Barclays PLC now owns 13,725 shares of the company’s stock valued at $123,000 after purchasing an additional 3,119 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Joint by 43.3% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 16,506 shares of the company’s stock valued at $148,000 after purchasing an additional 4,987 shares during the last quarter. Avondale Wealth Management boosted its position in Joint by 192.3% during the first quarter. Avondale Wealth Management now owns 19,000 shares of the company’s stock worth $248,000 after purchasing an additional 12,500 shares during the period. Finally, WINTON GROUP Ltd purchased a new position in shares of Joint in the third quarter worth about $179,000. 76.88% of the stock is currently owned by institutional investors.

Joint Stock Performance

Shares of NASDAQ JYNT opened at $15.93 on Monday. The stock has a market cap of $238.54 million, a price-to-earnings ratio of -21.24 and a beta of 1.58. Joint has a fifty-two week low of $7.31 and a fifty-two week high of $16.39. The firm’s 50-day simple moving average is $12.42 and its 200 day simple moving average is $10.31.

Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, March 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.04. The company had revenue of $30.61 million for the quarter, compared to analysts’ expectations of $29.63 million. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. On average, sell-side analysts predict that Joint will post 0.13 EPS for the current year.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.